RETN and polycystic ovary syndrome: The meta-analysis revealed that circulating resistin concentration was not significantly changed after metformin treatment in the patients with PCOS, with a corresponding SMD of -0.01 (95% CI: -0.49 to 0.45, P>0.05) (Fig 5).